Cerebrolysin: a forward thinking way to treat Alzheimer’s disease

Alzheimer’s disease affects many millions of people worldwide. Currently, alzheimer’s disease treatments only target the symptoms.

Cerebrolysin is part of a new and extensively clinically tested approach to treating this debilitating disease. Instead of trying to inhibit an enzyme that destroys neurotransmitters in the brain when alzheimer disease is contracted, cerebrolysin targets the causes.

Working to improve the function and the quantity of neurons and brain transmitters, cerebrolysin not only decreases the rate at which brain cells die, it’s known to block exitocins – now believed to be one of the main causes of alzheimer disease.

In short, by addressing the causes, cerebrolysin works to block and slow the onset of alzheimer disease preventatively.

What is Alzheimer’s disease?

In most cases, alzheimer disease symptoms are characterised by a loss of mental facilities that go far beyond the sufferer’s ability to recall facts, memories and maintain normal body functions. It’s well known that alzheimer disease not only affects the person with the condition but can also causes distress to those people around the sufferer – by not being able to remember loved ones and relatives, and eventually having to have professional care arranged – costly both financially and emotionally.

It affects a growing ageing population, and it’s currently estimated that around 25 – 30 million people worldwide have been diagnosed with the disease. It’s particularly present in older people where it’s known that one in five people over the age of 60 will have alzheimer’s disease.

The causes of alzheimer’s disease are being explored by scientists and doctors continually, but the main theory put forward is that the disease affects neurotransmitters and the way brain cells communicate with each other.

How traditional Alzheimer’s disease treatments work

Post-mortem studies have revealed that those with Alzheimer disease had a lower level of the brain neurotransmitter – Acetylcholine.

The enzyme that breaks down acetycholine function is therefore targeted by established drugs - like Donepezil (brand name Aricept®). This is a way of trying to slow down the damage to cells that are already diminished or damaged by the onset of the disease.

How cerebrolysin works

By looking at the everyday causes of Acetylcholine breakdown – and by looking at the way the drug Memantine works – it’s clear that excitoxins which damage the neurotransmitters may play a role in the progression of alzheimer disease.

Excitoxins can be linked to our diets – for example the presence of MSG or the sugar substitute, aspartate, in our foods. So if we deal with the damaging excitoxins, we can help the brain cells avoid attack in the first place.

Not only does cerebrolysin prevent damage, it also appears to help support and maintain neurons including: serotonin, choline (related to Acetylcholine) and noradrenaline.

Cerebrolysin (or CRB) appears to also affect synaptic responses in the hippocampus - the region of the brain responsible for functions of memory. In short; using cerbrolysin helps maintain vital repair processes and prevents damage to the Acetylcholine receptor groups in the brain.

Proven efficacy

In over 80 clinical trials with over 5000 patients with mild to moderate cases of the condition, using cerbrolysin was found to significantly improve cognitive powers. Taken I.V (intravenously) and I.M (via a muscle) the tests also showed continued effects: even after 4 weeks, patients remained stable for up to six months after stopping the therapy.

With the exception of the possibility of any mild side effects from an injection (like dizziness), there are no known side effects, and cerbrolysin is derived naturally. A normal dose is about a 5ml ampoule injected either in the muscle or in the vein each day for 5 days, then repeated for a period of 4 weeks. After a 2 month treatment break, the cycle is repeated. This means that with cerbrolysin price is key – 4 packets would be enough for 3 months at a time. Not only does the treatment work to prevent alzheimer’s disease, but it strengthens the neurons and neurotransmitters in the brain which improves the overall function.

What our customers say...

Send us your thoughts on this breakthrough product